It puts all the key nausea-fighting ingredients together in one daily capsule
In 2023, the AAP released guidelines allowing providers to begin offering these medications to patients aged 12 and older with obesity
The most common side effects include nausea, which affects roughly 20 to 44% of users depending on the study
According to the MHRA-approved Summary of Product Characteristics, the most frequently reported side effects include nausea (affecting approximately 40% of patients), vomiting, diarrhoea, constipation, dyspepsia (indigestion), and abdominal pain
The FDA stated it received an unspecified number of adverse event reports linked to compounded semaglutide that were due to dosing errors
Most side effects during the first few weeks are gastrointestinal: nausea, constipation, reduced appetite, and occasionally diarrhea